Delivery Order 75N93018D00010-75N93018F00001

Award Date 5/15/18
Potential Completion Date 5/14/19
Potential Value $56K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
BOWLING GREEN, NY 10004, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to International AIDS Vaccine Initiative Inc. (IAVI), a non-profit organization. The one-year, $105,353 cost-plus-fixed-fee contract supports IAVI's product development plans to advance HIV vaccine manufacturing efforts. This award does not utilize a set-aside designation. IAVI provides a range of research,...
This $8,398,301.00 cost-reimbursement delivery order was awarded on December 1, 2021 by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The award is part of NIAID's Preclinical And Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS) program and will support IAVI's preclinical and translational vaccine development work for HIV and other infectious diseases through...
This is a $1,327,640.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The contract is for "COORDINATION AND TECHNICAL SUPPORT" under NIAID's program for "PROCESS AND ANALYTICAL SUPPORT FOR DEVELOPMENT OF HIV VACCINES". IAVI, as the prime contractor, will provide a...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the International AIDS Vaccine Initiative (IAVI), a non-profit organization. The contract has a total ceiling value of $4,687,192.00 and is a delivery order under IAVI's existing indefinite delivery/indefinite quantity (IDIQ) contract with NIAID for preclinical services supporting the development of biopharmaceutical products, including vaccines, for infectious diseases....
This federal contract award, valued at $3,170,861.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global not-for-profit organization focused on the development of HIV vaccines. The contract provides for coordination and technical support services to advance the development of HIV vaccines and other infectious disease products. The contract is a delivery order issued under an Indefinite...
This federal contract award, valued at $1,707,175.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The contract supports process development for cell culture, upstream and downstream processes in the production of HIV-1 biomolecules, as part of NIAID's broader program for process and analytical support in the...
This is a cost-plus-fixed-fee delivery order under Contract HHSN272201600011I|HHSN27200006, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The $110,751 contract supports IAVI's efforts to develop product development plans to support HIV vaccine manufacturing. IAVI will provide a range of services including process development,...
This is a federal contract award from the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to International AIDS Vaccine Initiative Inc. (IAVI), a non-profit organization. The $713,906.00 award supports the development of nanoparticle-based delivery systems for human immunodeficiency virus type 1 (HIV-1) biomolecules. The contract has a performance period ending on December 15, 2021 and utilizes a Cost...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $432,452.00 cost-plus-fixed-fee delivery order contract to the International AIDS Vaccine Initiative (IAVI), a non-profit organization, for a feasibility assessment of HIV envelope protein antigens. The contract does not have a set-aside designation. IAVI has conducted research, development, and advocacy to advance vaccines and antibodies for infectious...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization focused on HIV vaccine development. The $1,098,404.00 cost-plus-fixed-fee contract provides funding for IAVI to perform cell line optimization and pre-master bank generation for SB 301, a vaccine candidate for hepatitis B virus (HBV). This work is being...
  • 75N93018D00010
    Indefinite Delivery Contract
  • 75N93018D00010-75N93018F00001
    Delivery Order

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The $55,936.00 cost-plus-fixed-fee contract is a delivery order under IAVI's IDIQ contract with NIAID for preclinical services supporting biopharmaceutical product development and vaccine development for HIV and other infectious diseases. The award provides funding for IAVI's work on the International AIDS Vaccine Initiative program, which includes conducting preclinical and analytical services to advance the development of HIV vaccines. The contract does not have a set-aside designation.

Generated 4/23/25, 10:45 AM